EUVIMEDEUVIMED entdecken
Crossref

Virtual Multi‐Phase Contrast Enhanced Liver MRI Using Deep Learning for Evaluating Hepatocellular Carcinoma

Yunfei Zhang, Xianling Qian, Changwu Zhou, Fei Wu, Ruofan Sheng, Yongming Dai, Mengsu Zeng iD

NMR in Biomedicine · 2026

DOI: 10.1002/nbm.70235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2026. Verfasst von Yunfei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Deep Learning, Carcinoma, Hepatocellular, Magnetic Resonance Imaging. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A deep learning (DL) model was developed to generate contrast‐enhanced MRI ( CE ‐MRI) at multiple enhancement phases (arterial, portal venous, transitional, and hepatobiliary phases) for detecting hepatocellular carcinoma (HCC). In total, 717 patients with HCC or other non‐HCC liver diseases were included, and the DL model was trained to synthesize CE ‐MRI. Three radiologists were invited to assess image quality, diagnostic performance, utility for the Liver Imaging Reporting and Data System (LI‐RADS), and image artifacts. The image quality of DL‐synthesized CE ‐MRI was non‐inferior to that of actual CE ‐MRI ( p ‐values < 0.001), and there was excellent agreement between DL‐synthesized and actual CE ‐MRI for visualizing the LI‐RADS major features. The diagnostic performance of DL‐synthesized CE ‐MRI for HCC (sensitivity = 0.880, specificity = 0.950, AUC = 0.915) was non‐inferior to that of actual CE ‐MRI. Notably, the proposed DL model required only 0.20–0.60 s to obtain multi‐phase CE ‐MRI, compared with more than 20 min needed for actual multi‐phase CE ‐MRI. Overall, the observed advantages of the proposed DL‐based strategy included eliminating the need for GBCAs, high time efficiency, comparable image quality, high diagnostic performance, validity for LI‐RADS, and robustness to image artifacts, indicating potential for clinical translation that may benefit both patients and healthcare providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsDeep LearningCarcinoma, HepatocellularMagnetic Resonance ImagingContrast MediaLiverHumansFemaleMaleMiddle AgedAged

Stichwörter der Autor:innen

MRI synthesiscontrast‐enhanced MRIdeep learninghepatocellular carcinoma

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China.
  • Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.

ORCID-Profile: Mengsu Zeng

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Shanghai Municipal Health Commission
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Zhang, Y., Qian, X., Zhou, C., Wu, F., Sheng, R., Dai, Y., & Zeng, M. (2026). Virtual Multi‐Phase Contrast Enhanced Liver MRI Using Deep Learning for Evaluating Hepatocellular Carcinoma. NMR in Biomedicine. https://doi.org/10.1002/nbm.70235

Vancouver

Zhang Y, Qian X, Zhou C, Wu F, Sheng R, Dai Y, et al. Virtual Multi‐Phase Contrast Enhanced Liver MRI Using Deep Learning for Evaluating Hepatocellular Carcinoma. NMR in Biomedicine. 2026. doi:10.1002/nbm.70235

BibTeX
@article{Zhang2026,
  author = {Zhang, Yunfei and Qian, Xianling and Zhou, Changwu and Wu, Fei and Sheng, Ruofan and Dai, Yongming and Zeng, Mengsu},
  title = {Virtual Multi‐Phase Contrast Enhanced Liver MRI Using Deep Learning for Evaluating Hepatocellular Carcinoma},
  journal = {NMR in Biomedicine},
  year = {2026},
  doi = {10.1002/nbm.70235}
}
Kostenlos starten →